300 related articles for article (PubMed ID: 24891508)
1. Genomic determinants of gene regulation by 1,25-dihydroxyvitamin D3 during osteoblast-lineage cell differentiation.
Meyer MB; Benkusky NA; Lee CH; Pike JW
J Biol Chem; 2014 Jul; 289(28):19539-54. PubMed ID: 24891508
[TBL] [Abstract][Full Text] [Related]
2. Selective Distal Enhancer Control of the Mmp13 Gene Identified through Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) Genomic Deletions.
Meyer MB; Benkusky NA; Pike JW
J Biol Chem; 2015 Apr; 290(17):11093-107. PubMed ID: 25773540
[TBL] [Abstract][Full Text] [Related]
3. Selective regulation of Mmp13 by 1,25(OH)
Meyer MB; Benkusky NA; Onal M; Pike JW
J Steroid Biochem Mol Biol; 2016 Nov; 164():258-264. PubMed ID: 26348136
[TBL] [Abstract][Full Text] [Related]
4. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
5. Mineralization of three-dimensional osteoblast cultures is enhanced by the interaction of 1α,25-dihydroxyvitamin D3 and BMP2 via two specific vitamin D receptors.
Chen J; Dosier CR; Park JH; De S; Guldberg RE; Boyan BD; Schwartz Z
J Tissue Eng Regen Med; 2016 Jan; 10(1):40-51. PubMed ID: 23784946
[TBL] [Abstract][Full Text] [Related]
6. The RUNX2 cistrome in osteoblasts: characterization, down-regulation following differentiation, and relationship to gene expression.
Meyer MB; Benkusky NA; Pike JW
J Biol Chem; 2014 Jun; 289(23):16016-31. PubMed ID: 24764292
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription.
Zella LA; Meyer MB; Nerenz RD; Lee SM; Martowicz ML; Pike JW
Mol Endocrinol; 2010 Jan; 24(1):128-47. PubMed ID: 19897601
[TBL] [Abstract][Full Text] [Related]
8. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3.
Zella LA; Kim S; Shevde NK; Pike JW
Mol Endocrinol; 2006 Jun; 20(6):1231-47. PubMed ID: 16497728
[TBL] [Abstract][Full Text] [Related]
9. Bone-specific transcription factor Runx2 interacts with the 1alpha,25-dihydroxyvitamin D3 receptor to up-regulate rat osteocalcin gene expression in osteoblastic cells.
Paredes R; Arriagada G; Cruzat F; Villagra A; Olate J; Zaidi K; van Wijnen A; Lian JB; Stein GS; Stein JL; Montecino M
Mol Cell Biol; 2004 Oct; 24(20):8847-61. PubMed ID: 15456860
[TBL] [Abstract][Full Text] [Related]
10. Functional cooperation between CCAAT/enhancer-binding proteins and the vitamin D receptor in regulation of 25-hydroxyvitamin D3 24-hydroxylase.
Dhawan P; Peng X; Sutton AL; MacDonald PN; Croniger CM; Trautwein C; Centrella M; McCarthy TL; Christakos S
Mol Cell Biol; 2005 Jan; 25(1):472-87. PubMed ID: 15601867
[TBL] [Abstract][Full Text] [Related]
11. The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes.
Eelen G; Verlinden L; van Camp M; van Hummelen P; Marchal K; de Moor B; Mathieu C; Carmeliet G; Bouillon R; Verstuyf A
J Bone Miner Res; 2004 Jan; 19(1):133-46. PubMed ID: 14753745
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of 1α,25-dihydroxyvitamin D3-dependent chromatin accessibility of early vitamin D receptor target genes.
Seuter S; Pehkonen P; Heikkinen S; Carlberg C
Biochim Biophys Acta; 2013 Dec; 1829(12):1266-75. PubMed ID: 24185200
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta-induced dissociation between vitamin D receptor level and 1,25-dihydroxyvitamin D3 action in osteoblast-like cells.
Staal A; Birkenhäger JC; Pols HA; Buurman CJ; Vink-van Wijngaarden T; Kleinekoort WM; van den Bemd GJ; van Leeuwen JP
Bone Miner; 1994 Jul; 26(1):27-42. PubMed ID: 7950503
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells.
Kong J; Li YC
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E916-24. PubMed ID: 16368784
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of Enhancer-mediated Hormonal Control of Vitamin D Receptor Gene Expression in Target Cells.
Lee SM; Meyer MB; Benkusky NA; O'Brien CA; Pike JW
J Biol Chem; 2015 Dec; 290(51):30573-86. PubMed ID: 26504088
[TBL] [Abstract][Full Text] [Related]
16. The 1,25(OH)2D3-regulated transcription factor MN1 stimulates vitamin D receptor-mediated transcription and inhibits osteoblastic cell proliferation.
Sutton AL; Zhang X; Ellison TI; Macdonald PN
Mol Endocrinol; 2005 Sep; 19(9):2234-44. PubMed ID: 15890672
[TBL] [Abstract][Full Text] [Related]
17. Evidence for coordinated regulation of osteoblast function by 1,25-dihydroxyvitamin D3 and parathyroid hormone.
van Leeuwen JP; Birkenhäger JC; van den Bemd GC; Pols HA
Biochim Biophys Acta; 1996 Jun; 1312(1):54-62. PubMed ID: 8679716
[TBL] [Abstract][Full Text] [Related]
18. Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization.
van Driel M; Koedam M; Buurman CJ; Roelse M; Weyts F; Chiba H; Uitterlinden AG; Pols HA; van Leeuwen JP
J Cell Biochem; 2006 Oct; 99(3):922-35. PubMed ID: 16741965
[TBL] [Abstract][Full Text] [Related]
19. The osteoblast to osteocyte transition: epigenetic changes and response to the vitamin D3 hormone.
St John HC; Bishop KA; Meyer MB; Benkusky NA; Leng N; Kendziorski C; Bonewald LF; Pike JW
Mol Endocrinol; 2014 Jul; 28(7):1150-65. PubMed ID: 24877565
[TBL] [Abstract][Full Text] [Related]
20. The Vitamin D Receptor in Osteoblast-Lineage Cells Is Essential for the Proresorptive Activity of 1α,25(OH)2D3 In Vivo.
Mori T; Horibe K; Koide M; Uehara S; Yamamoto Y; Kato S; Yasuda H; Takahashi N; Udagawa N; Nakamichi Y
Endocrinology; 2020 Nov; 161(11):. PubMed ID: 32987399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
